Current Molecular Pharmacology
Title:Editorial (Thematic Issue: Clinical Advances in Immuno-oncology – Progress Towards Selective Cure)
Volume: 9
Author(s): Xin Liu and Chandra P. Belani
Affiliation:
Export Options
About this article
Cite this article as:
Liu Xin and P. Belani Chandra, Editorial (Thematic Issue: Clinical Advances in Immuno-oncology – Progress Towards Selective Cure), Current Molecular Pharmacology 2016; 9 (3) . https://dx.doi.org/10.2174/1874467208999150716103938
DOI https://dx.doi.org/10.2174/1874467208999150716103938 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Highly Selective MEK Inhibitors
Current Enzyme Inhibition Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Current Pediatric Reviews The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Current Status and Perspectives in Peptide Receptor Radiation Therapy
Current Pharmaceutical Design Using Fragment-Based Technologies to Target Protein-Protein Interactions
Current Pharmaceutical Design The Urokinase Receptor Interactome
Current Pharmaceutical Design Realizing the Potential of Blueberry as Natural Inhibitor of Metastasis and Powerful Apoptosis Inducer: Tapping the Treasure Trove for Effective Regulation of Cell Signaling Pathways
Anti-Cancer Agents in Medicinal Chemistry The Role of Phenolic Compounds in the Fight against Cancer – A Review
Anti-Cancer Agents in Medicinal Chemistry Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro
Anti-Cancer Agents in Medicinal Chemistry Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds CXXC5 Associates with Smads to Mediate TNF-α Induced Apoptosis
Current Molecular Medicine Furanocoumarin A: A Novel Anticancer Agent on Human Lung Cancer A549 Cells from Fructus liquidambaris
Anti-Cancer Agents in Medicinal Chemistry Tumor Biomarkers: Clinical Utility, Promises and Problems
Applied Clinical Research, Clinical Trials and Regulatory Affairs Current Developments of Coumarin Compounds in Medicinal Chemistry
Current Pharmaceutical Design Phytochemicals, Medicinal and Food Applications of Shatavari (Asparagus racemosus): An Updated Review
The Natural Products Journal Hypertension and Angiogenesis
Current Pharmaceutical Design Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
Current Computer-Aided Drug Design Therapeutic Potential of microRNA Against Th2-associated Immune Disorders
Current Topics in Medicinal Chemistry